Assertio Holdings, Inc. (ASRT) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19
	10-K	10-K	10-K	10-K
Revenues:
Sympazan	1.8
Otrexup	11.1
Commercialization agreement revenue, net			11.3	118.6
Product sales, net	155.1	109.4	92.1	108.8
Other		1.6	2.9	2.1
Total revenues	156.2	111.0	106.3	229.5
Revenue growth [+]	40.7%	4.5%	-53.7%
Commercialization agreement revenue, net			-90.5%
Product sales, net	41.8%	18.8%	-15.4%
SPRIX	5.0%	-21.7%
Cost of goods sold	37.4	19.7	19.9	9.5
Gross profit	118.8	91.3	86.4	220.0
Gross margin	76.0%	82.2%	81.3%	95.9%
Selling, general and administrative	46.8	52.6	104.3	108.9
Research and development			4.2	10.1
Other operating expenses	-18.7	-3.9
EBITDA [+]	91.5	43.5	-20.5	102.2
EBITDA growth	110.3%	-312.4%	-120.0%
EBITDA margin	58.6%	39.2%	-19.3%	44.5%
Depreciation and amortization	0.8	1.0	1.6	1.2
EBITA	90.7	42.5	-22.1	101.0
EBITA margin	58.1%	38.3%	-20.8%	44.0%
Amortization of intangibles	32.6	28.1	24.8	101.8
EBIT [+]	58.1	14.4	-46.9	-0.7
EBIT growth	302.7%	-130.8%	6180.7%
EBIT margin	37.2%	13.0%	-44.1%	-0.3%
Non-recurring items [+]	18.7	5.0	35.2	193.7
Asset impairment			17.4	189.8
Loss on contingent liability	18.7	3.9
Interest expense	8.0	10.2	15.9	58.4
Interest expense	8.0	10.2	15.9	58.4
Other income (expense), net [+]	-0.3	0.2	52.6	30.3
Gain (loss) on debt retirement			-56.1	26.4
Other	-0.3	0.2	-3.2	3.9
Pre-tax income	31.2	-0.6	-45.5	-222.5
Income taxes	-78.5	0.7	-17.4	-5.3
Tax rate			38.2%	2.4%
Net income	109.6	-1.3	-28.1	-217.2
Net margin	70.2%	-1.2%	-26.5%	-94.6%

Basic EPS [+]	$2.33	($0.03)	($1.07)	($3.07)
Growth	-7959.5%	-97.2%	-65.0%
Diluted EPS [+]	$2.01	($0.03)	($1.07)	($3.07)
Growth	-6857.6%	-97.2%	-65.0%

Shares outstanding (basic) [+]	47.0	43.2	26.2	70.7
Growth	8.9%	64.7%	-62.9%
Shares outstanding (diluted) [+]	54.7	43.2	26.2	70.7
Growth	26.6%	64.7%	-62.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.